Forte Biosciences, Inc.

Rachunek Zysków i Strat


Profil spółki
Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 0
EBIT TTM (mln): -36
index 0 1 2 3 4 5 6 7 8 9
Rok finansowy 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 18 0 0 0 0 0 0
Przychód Δ r/r 0.0% -3.9% -16.3% 43890.2% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Marża brutto 100.0% 100.0% 100.0% 100.0% -inf% -inf% -inf% 0.0% -inf% 0.0%
EBIT (mln) -23 -32 -38 -46 -4 18 -21 -14 -32 -37
EBIT Δ r/r 0.0% 37.8% 18.9% 21.9% -91.1% -538.8% -220.5% -35.3% 133.8% 12.7%
EBIT (%) -45007.8% -64573.5% -91778.0% -254.2% 0.0% 0.0% 0.0% 0.0% 0.0% nan
Koszty finansowe (mln) -0 -2 -1 -1 -4 0 0 -0 0 0
EBITDA (mln) -23 -35 -40 -48 -4 18 -21 -14 -32 -37
EBITDA(%) -44952.9% -71551.0% -97407.3% -266.3% 0.0% 0.0% 0.0% 0.0% 0.0% nan
Podatek (mln) -0 -4 -3 2 -0 32 0 -0 0 0
Zysk Netto (mln) -23 -33 -39 -49 -4 -79 -22 -14 -31 -35
Zysk netto Δ r/r 0.0% 45.2% 16.3% 25.8% -91.7% 1831.7% -72.4% -36.1% 127.1% 12.7%
Zysk netto (%) -45207.8% -68322.4% -94948.8% -271.4% 0.0% 0.0% 0.0% 0.0% 0.0% nan
EPS -18.69 -27.14 -39.97 -36.61 -1.93 -10.67 -1.55 -0.8 -1.0 -12.17
EPS (rozwodnione) -18.69 -27.14 -39.97 -36.61 -1.93 -10.67 -1.55 -0.8 -1.0 -12.17
Ilośc akcji (mln) 1 1 1 1 2 7 14 17 32 3
Ważona ilośc akcji (mln) 1 1 1 1 2 7 14 17 32 3
Waluta USD USD USD USD USD USD USD USD USD USD